M. Mauer

Discipline

Psychologie (2) Sociologie (1) Economies et finances (1)

Type de document

Articles (6) Recensions (2)

Co-auteur

A.D. Wagner

F. Lordick

M.H. Moehler

H.I. Grabsch

T. Yoshikawa

W. Yang

R. Wong

M. Weller

D. Wang

N. Van Grieken

M.J. van den Bent

V.E. Torres

M. Tokunaga

H. Tighiouart

P. Thuss-Patience

M. Terashima

M. Terada

M. J. Taphoorn

R. Stupp

E.C. Smyth

E. Smyth

M.G. Shlipak

E. Selvin

J.C. Seegmiller

Y. Sang

A.D. Rule

P. Rossing

R. Rodby

S.Y. Rha

N.R. Powe

E.D. Poggio

D. Osoba

M. Nilsson

R.G. Nelson

G. Navis

L Mueller

M. Moehler

R.O. Mirimanoff

U. Martens

S. Marreaud

C. Marosi

A.S. Levey

M. Knödler

K. Kataoka

A.B. Karger

Y.K. Kang

R. Kalil

L.A. Inker

K. Haustermans

O.M. Gutiérrez

V. Gudnason

A. Grubb

T. Greene

M.E. Grams

A. Giraut

M. Froissart

P. Forsyth

M.M. Estrella

N.D. Eneanya

A. Elme

F. Efficace

A. Doria

O. De Witte

V. Cristina

D.C. Crews

S.J. Couture

J. Coresh

C. Coens

A. Cats

J. G. Cairncross

C. Caballero

A. Bottomley

N. Boku

S.H. Ballew

Date

Source

Serveur académique Lausannois (6)

Mot-clé

cancer (5) Cancer (5) Cancer (5) survie (4) Survival (4) gestion (3) Treatment (3) Chemotherapy (3) Management (3) Human beings (3) Chemotherapy (3) Management (3) norme (2) qualité de vie (2) oncologie (2) analyse (2) dose (2) maladie (2) procès (2) Surgery (2) Will (2) Tumors (2) Theater (2) Surgery (2) Quality of life (2) Prognosis (2) Patients (2) Oncology (2) Adjustable rate mortgages (2) Manufacturers' agents (2)

Documents écrit par M. Mauer (6) | parle de M. Mauer (1)

New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race.

L.A. Inker et al. (4 nov. 2021)

Multidisciplinary management of stage II-III gastric and gastro-oesophageal junction cancer.

A.D. Wagner et al.

EORTC-1203-GITCG - the "INNOVATION"-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group.

A.D. Wagner et al. (24 mai 2019)

Inappropriate Grading of Adverse Events in Cancer Clinical Trials-Reply.

V. Cristina et al. (1 févr. 2019)

VESTIGE: Adjuvant Immunotherapy in Patients With Resected Esophageal, Gastroesophageal Junction and Gastric Cancer Following Preoperative Chemotherapy With High Risk for Recurrence (N+ and/or R1): An Open Label Randomized Controlled Phase-2-Study.

E. Smyth et al. (2019)

The prognostic value of health-related quality-of-life data in predicting survival in glioblastoma cancer patients: results from an international randomised phase III EORTC Brain Tumour and Radiation Oncology Groups, and NCIC Clinical Trials Group study.

M. Mauer et al. (2007)